| Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
|---|
| C016403 |
2,4-dinitrotoluene |
2,4-dinitrotoluene affects the expression of PPRC1 mRNA | affects expression | 21346803
|
| D000082 |
Acetaminophen |
Acetaminophen affects the expression of PPRC1 mRNA | affects expression | 17562736
|
| D016604 |
Aflatoxin B1 |
Aflatoxin B1 affects the expression of PPRC1 protein | affects expression | 20106945
|
| D015123 |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of PPRC1 mRNA | decreases expression | 20382639
|
| D020122 |
tert-Butylhydroperoxide |
tert-Butylhydroperoxide results in increased expression of PPRC1 mRNA | increases expression | 15336504
|
| D016572 |
Cyclosporine |
Cyclosporine results in increased expression of PPRC1 mRNA | increases expression | 20106945
|
| D004997 |
Ethinyl Estradiol |
Ethinyl Estradiol results in increased expression of PPRC1 mRNA | increases expression | 17942748
|
| D004997 |
Ethinyl Estradiol |
[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of PPRC1 mRNA | affects cotreatment|increases expression | 17942748
|
| D008727 |
Methotrexate |
PPRC1 protein affects the susceptibility to Methotrexate | affects response to substance | 16217747
|
| D010634 |
Phenobarbital |
Phenobarbital results in decreased expression of PPRC1 mRNA | decreases expression | 19482888
|
| C006253 |
pirinixic acid |
[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of PPRC1 mRNA | affects binding|increases activity|increases expression | 19710929
|
| C006253 |
pirinixic acid |
pirinixic acid results in decreased expression of PPRC1 mRNA | decreases expression | 17426115
|
| D018038 |
Sodium Selenite |
Sodium Selenite results in increased expression of PPRC1 mRNA | increases expression | 18175754
|
| D013749 |
Tetrachlorodibenzodioxin |
[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of PPRC1 mRNA | affects cotreatment|increases expression | 17942748
|
| D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in decreased expression of PPRC1 mRNA | decreases expression | 20159946
|
| D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in increased expression of PPRC1 mRNA | increases expression | 17942748
|
| Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
|---|
| MESH:D000014 |
Abnormalities, Drug-Induced |
|
Methotrexate |
15.23 | 12039119 |
| MESH:D000014 |
Abnormalities, Drug-Induced |
|
Phenobarbital |
15.23 | 6195326 |
| MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
15.23 | 15322242 14514962 11752688 |
| MESH:D000152 |
Acne Vulgaris |
|
Ethinyl Estradiol |
4.12 | 17505938 |
| MESH:D055371 |
Acute Lung Injury |
|
pirinixic acid |
3.23 | 18653653 |
| MESH:D000230 |
Adenocarcinoma |
|
Ethinyl Estradiol |
1.83 | 14692618 |
| MESH:D018248 |
Adenoma, Liver Cell |
|
Phenobarbital |
18.23 | 17620307 |
| MESH:D018248 |
Adenoma, Liver Cell |
|
pirinixic acid |
18.23 | 16434500 |
| MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
18.23 | 16835633 |
| MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
3.05 | 11748828 |
| MESH:D000799 |
Angioedema |
|
Acetaminophen |
4.02 | 10982225 |
| MESH:D001161 |
Arteriosclerosis |
|
Ethinyl Estradiol |
3.60 | 11256880 |
| MESH:D001169 |
Arthritis, Experimental |
|
Ethinyl Estradiol |
2.73 | 15885639 |
| MESH:D001172 |
Arthritis, Rheumatoid |
|
Methotrexate |
3.12 | 17286800 |
| MESH:D001321 |
Autistic Disorder |
|
Acetaminophen |
1.41 | 18445737 |
| MESH:D001778 |
Blood Coagulation Disorders |
|
pirinixic acid |
9.14 | 19483382 |
| MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
9.14 | 12125929 |
| MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
3.96 | 15340226 |
| MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.83 | 15746008 |
| MESH:D001943 |
Breast Neoplasms |
|
Methotrexate |
2.28 | 16978400 |
| MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
2.28 | 20435547 |
| MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
2.89 | 16835633 |
| MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,4-dinitrotoluene |
6.69 | 16705839 |
| MESH:D006528 |
Carcinoma, Hepatocellular |
|
Acetaminophen |
6.69 | 3084413 |
| MESH:D006528 |
Carcinoma, Hepatocellular |
|
Aflatoxin B1 |
6.69 | 21507988 12907637 12619106 |
| MESH:D006528 |
Carcinoma, Hepatocellular |
|
Phenobarbital |
6.69 | 6705139 1701930 20935162 17173139 20007298 |
| MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.42 | 18670907 16120746 18850075 |
| MESH:D002386 |
Cataract |
|
Acetaminophen |
2.64 | 10977129 |
| MESH:D002471 |
Cell Transformation, Neoplastic |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
6.80 | 20889678 |
| MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cyclosporine |
6.80 | 12371664 |
| MESH:D002493 |
Central Nervous System Diseases |
|
Phenobarbital |
4.39 | 4080065 |
| MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
3.26 | 16835633 |
| MESH:D002779 |
Cholestasis |
|
Cyclosporine |
13.82 | 19486331 |
| MESH:D002779 |
Cholestasis |
|
Ethinyl Estradiol |
13.82 | 15861022 17110522 16105132 17681005 16919318 17333356 11677210 |
| MESH:D002779 |
Cholestasis |
|
pirinixic acid |
13.82 | 19176532 |
| MESH:D019457 |
Chromosome Breakage |
|
Sodium Selenite |
4.89 | 15894690 |
| MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
2.14 | 16354765 15340226 12621046 8697196 15668235 |
| MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
3.16 | 17141729 14669216 |
| MESH:D019465 |
Craniofacial Abnormalities |
|
Methotrexate |
2.78 | 12039119 9562676 |
| MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
2.78 | 15322242 10048152 20055451 |
| MESH:D003490 |
Cyanosis |
|
2,4-dinitrotoluene |
4.15 | 18551238 |
| MESH:D003550 |
Cystic Fibrosis |
|
Methotrexate |
4.34 | 19747007 |
| MESH:D003876 |
Dermatitis, Atopic |
|
pirinixic acid |
2.47 | 18249437 |
| MESH:D003882 |
Dermatomyositis |
|
Methotrexate |
5.25 | 20191521 |
| MESH:D003920 |
Diabetes Mellitus |
|
Sodium Selenite |
3.87 | 16285004 |
| MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
1.69 | 17107852 |
| MESH:D056486 |
Drug-Induced Liver Injury |
|
2,4-dinitrotoluene |
9.21 | 21346803 18551238 |
| MESH:D056486 |
Drug-Induced Liver Injury |
|
Acetaminophen |
9.21 | 15619225 16485898 16081117 11529661 15968718 14725611 19085960 12540782 12392966 10774834 16177239 12153990 16109766 2444490 19420014 12705907 17522070 11743745 10915739 11739529 11287661 14550746 12958197 12594235 11834606 19370779 14986274 16781746 16227642 19923254 17906064 18071297 19739265 17562736 11421492 19416960 16393943 19164858 18713872 10663392 11461765 |
| MESH:D056486 |
Drug-Induced Liver Injury |
|
Sodium Selenite |
9.21 | 15131321 |
| MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
9.21 | 20420201 |
| MESH:D056487 |
Drug-Induced Liver Injury, Chronic |
|
Acetaminophen |
4.27 | 19426721 |
| MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
2.84 | 11462148 |
| MESH:D004421 |
Dystonia |
|
Phenobarbital |
4.12 | 1851702 |
| MESH:D004487 |
Edema |
|
pirinixic acid |
6.90 | 12083418 |
| MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
6.90 | 12711302 11000095 |
| MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
4.08 | 16714409 18230668 15322242 |
| MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Ethinyl Estradiol |
3.31 | 12538720 |
| MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
3.12 | 9294722 10568697 |
| MESH:D004831 |
Epilepsies, Myoclonic |
|
Phenobarbital |
4.25 | 3659116 |
| MESH:D004828 |
Epilepsies, Partial |
|
Phenobarbital |
4.04 | 11558140 3922381 |
| MESH:D004827 |
Epilepsy |
|
Phenobarbital |
2.94 | 20417680 |
| MESH:D004832 |
Epilepsy, Absence |
|
Phenobarbital |
3.64 | 6401628 |
| MESH:D017029 |
Epilepsy, Complex Partial |
|
Phenobarbital |
4.39 | 7750514 |
| MESH:D004830 |
Epilepsy, Tonic-Clonic |
|
Phenobarbital |
4.17 | 3659116 |
| MESH:D004938 |
Esophageal Neoplasms |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
2.10 | 20426865 |
| MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
3.09 | 11564622 |
| MESH:D005234 |
Fatty Liver |
|
Cyclosporine |
13.65 | 19224547 |
| MESH:D005234 |
Fatty Liver |
|
Ethinyl Estradiol |
13.65 | 15345470 |
| MESH:D005234 |
Fatty Liver |
|
pirinixic acid |
13.65 | 20131406 19236843 |
| MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.59 | 11858732 |
| MESH:D005355 |
Fibrosis |
|
Cyclosporine |
8.95 | 12168785 12639820 |
| MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
8.95 | 20067830 |
| MESH:D005756 |
Gastritis |
|
Acetaminophen |
3.85 | 16983495 |
| MESH:D005885 |
Gingival Hyperplasia |
|
Cyclosporine |
4.37 | 8708960 |
| MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.77 | 10696789 |
| MESH:D006086 |
Graft vs Host Disease |
|
Methotrexate |
5.29 | 16518429 |
| MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
2.38 | 10048152 11294989 |
| MESH:D006333 |
Heart Failure |
|
pirinixic acid |
2.60 | 20558911 |
| MESH:D006457 |
Hemoglobinuria, Paroxysmal |
|
Cyclosporine |
4.58 | 15720958 |
| MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.44 | 11000095 |
| MESH:D006529 |
Hepatomegaly |
|
Phenobarbital |
15.22 | 16109766 |
| MESH:D006529 |
Hepatomegaly |
|
pirinixic acid |
15.22 | 16221962 19772884 18467677 19176532 |
| MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
15.22 | 15340226 12621046 16120746 |
| MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
4.22 | 15340226 16959395 8697196 18606429 16354765 |
| MESH:D006930 |
Hyperalgesia |
|
Acetaminophen |
2.79 | 16870215 |
| MESH:D006943 |
Hyperglycemia |
|
pirinixic acid |
3.29 | 20558911 |
| MESH:D006973 |
Hypertension |
|
Cyclosporine |
5.07 | 10903974 |
| MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
5.07 | 18850075 18670907 |
| MESH:D007021 |
Hypospadias |
|
Ethinyl Estradiol |
3.95 | 16569931 16945680 |
| MESH:D007247 |
Infertility, Female |
|
Ethinyl Estradiol |
3.58 | 12013081 |
| MESH:D007248 |
Infertility, Male |
|
Ethinyl Estradiol |
2.56 | 17937319 |
| MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
1.91 | 12878042 12200463 |
| MESH:D007333 |
Insulin Resistance |
|
pirinixic acid |
7.54 | 16306350 |
| MESH:D007333 |
Insulin Resistance |
|
Sodium Selenite |
7.54 | 14714311 |
| MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
3.44 | 16580747 |
| MESH:D007638 |
Keratoconjunctivitis Sicca |
|
Cyclosporine |
4.62 | 15604871 |
| MESH:D007674 |
Kidney Diseases |
|
Acetaminophen |
5.99 | 12587719 15629191 |
| MESH:D007674 |
Kidney Diseases |
|
Cyclosporine |
5.99 | 8314463 10903974 18776723 |
| MESH:D007680 |
Kidney Neoplasms |
|
2,4-dinitrotoluene |
7.58 | 16705839 |
| MESH:D007680 |
Kidney Neoplasms |
|
Cyclosporine |
7.58 | 12371664 |
| MESH:D007805 |
Language Development Disorders |
|
Methotrexate |
5.22 | 9562676 |
| MESH:D008103 |
Liver Cirrhosis |
|
Methotrexate |
7.15 | 14986274 |
| MESH:D008103 |
Liver Cirrhosis |
|
Phenobarbital |
7.15 | 21047994 |
| MESH:D008106 |
Liver Cirrhosis, Experimental |
|
pirinixic acid |
2.16 | 15474484 |
| MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
2.16 | 12878042 |
| MESH:D008107 |
Liver Diseases |
|
Acetaminophen |
4.01 | 12587719 12969438 19460945 19784758 11587558 16610002 16611625 19014921 |
| MESH:D008107 |
Liver Diseases |
|
Phenobarbital |
4.01 | 19363144 |
| MESH:D017114 |
Liver Failure, Acute |
|
Acetaminophen |
3.34 | 16871587 17185352 |
| MESH:D008113 |
Liver Neoplasms |
|
Aflatoxin B1 |
11.00 | 9163691 2125692 18177683 15890375 |
| MESH:D008113 |
Liver Neoplasms |
|
Phenobarbital |
11.00 | 19812893 8742319 19482888 15975961 19073162 21047994 |
| MESH:D008113 |
Liver Neoplasms |
|
pirinixic acid |
11.00 | 20007298 15890375 16377806 |
| MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
11.00 | 16984957 |
| MESH:D008114 |
Liver Neoplasms, Experimental |
|
Aflatoxin B1 |
10.21 | 8603461 |
| MESH:D008114 |
Liver Neoplasms, Experimental |
|
Phenobarbital |
10.21 | 17172636 18308698 2563599 6150874 1399818 |
| MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
10.21 | 12151625 |
| MESH:D017563 |
Lung Diseases, Interstitial |
|
Methotrexate |
5.20 | 18516814 |
| MESH:D008175 |
Lung Neoplasms |
|
Aflatoxin B1 |
2.32 | 14755239 |
| MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
2.32 | 11884234 19555203 |
| MESH:D008223 |
Lymphoma |
|
Methotrexate |
4.03 | 17352296 |
| MESH:D016393 |
Lymphoma, B-Cell |
|
Sodium Selenite |
4.18 | 14737004 |
| MESH:D008546 |
Melanoma, Experimental |
|
Acetaminophen |
3.71 | 19513568 |
| MESH:D008664 |
Metal Metabolism, Inborn Errors |
|
Cyclosporine |
4.96 | 16801185 |
| MESH:D052016 |
Mucositis |
|
Methotrexate |
5.43 | 17488658 |
| MESH:D009135 |
Muscular Diseases |
|
pirinixic acid |
3.64 | 16239165 |
| MESH:D009203 |
Myocardial Infarction |
|
pirinixic acid |
2.18 | 19151258 |
| MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
3.11 | 12213967 |
| MESH:D015428 |
Myocardial Reperfusion Injury |
|
pirinixic acid |
3.03 | 16411023 |
| MESH:D020191 |
Myoclonic Epilepsies, Progressive |
|
Phenobarbital |
4.63 | 17484760 |
| MESH:D009336 |
Necrosis |
|
2,4-dinitrotoluene |
4.01 | 18551238 |
| MESH:D009369 |
Neoplasms |
|
pirinixic acid |
1.99 | 17405874 |
| MESH:D009402 |
Nephrosis, Lipoid |
|
Cyclosporine |
4.62 | 17954296 |
| MESH:D009404 |
Nephrotic Syndrome |
|
Cyclosporine |
3.38 | 19348381 18481113 |
| MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
3.34 | 14600291 |
| MESH:D019636 |
Neurodegenerative Diseases |
|
Acetaminophen |
2.96 | 18514411 |
| MESH:D009765 |
Obesity |
|
pirinixic acid |
1.84 | 20558911 |
| MESH:D009784 |
Occupational Diseases |
|
2,4-dinitrotoluene |
3.53 | 12819281 16049721 |
| MESH:D010018 |
Osteomalacia |
|
Phenobarbital |
4.52 | 17016548 |
| MESH:D010146 |
Pain |
|
Acetaminophen |
2.48 | 16870215 |
| MESH:D010190 |
Pancreatic Neoplasms |
|
Phenobarbital |
2.53 | 16965848 |
| MESH:D016584 |
Panic Disorder |
|
Ethinyl Estradiol |
3.80 | 11578682 |
| MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.42 | 12520081 |
| MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.69 | 18163543 |
| MESH:D011230 |
Precancerous Conditions |
|
Cyclosporine |
9.30 | 12371664 |
| MESH:D011230 |
Precancerous Conditions |
|
Phenobarbital |
9.30 | 2563599 |
| MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
3.34 | 11222880 11118676 11896295 11399792 |
| MESH:D011471 |
Prostatic Neoplasms |
|
Sodium Selenite |
3.38 | 18760546 |
| MESH:D011537 |
Pruritus |
|
Ethinyl Estradiol |
3.47 | 16919318 15861022 |
| MESH:D019310 |
Pseudolymphoma |
|
Phenobarbital |
4.67 | 12752131 |
| MESH:D011565 |
Psoriasis |
|
Cyclosporine |
6.02 | 16882103 |
| MESH:D011565 |
Psoriasis |
|
Methotrexate |
6.02 | 17410198 |
| MESH:D051437 |
Renal Insufficiency |
|
Methotrexate |
4.85 | 17352296 |
| MESH:D015427 |
Reperfusion Injury |
|
pirinixic acid |
2.43 | 19058328 |
| MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.96 | 18990726 |
| MESH:D012640 |
Seizures |
|
2,4-dinitrotoluene |
6.17 | 18551238 |
| MESH:D012640 |
Seizures |
|
Phenobarbital |
6.17 | 11442880 3137016 16876388 4039156 |
| MESH:D003294 |
Seizures, Febrile |
|
Phenobarbital |
4.98 | 6407741 |
| MESH:D012878 |
Skin Neoplasms |
|
tert-Butylhydroperoxide |
5.75 | 8532709 |
| MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
5.75 | 16192470 |
| MESH:D013088 |
Spermatocele |
|
Ethinyl Estradiol |
4.12 | 16709447 |
| MESH:D013576 |
Syndactyly |
|
Methotrexate |
5.16 | 9562676 |
| MESH:D019851 |
Thrombophilia |
|
Ethinyl Estradiol |
3.74 | 11994571 |
| MESH:D013927 |
Thrombosis |
|
Ethinyl Estradiol |
3.25 | 15669648 |
| MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
4.08 | 12697716 |
| MESH:D013964 |
Thyroid Neoplasms |
|
Phenobarbital |
3.14 | 1399818 |
| MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,4-dinitrotoluene |
2.32 | 16049721 |
| MESH:D014571 |
Urologic Neoplasms |
|
2,4-dinitrotoluene |
4.47 | 10091137 |
| MESH:D014581 |
Urticaria |
|
Acetaminophen |
3.09 | 10982225 |
| MESH:D014594 |
Uterine Neoplasms |
|
Ethinyl Estradiol |
3.42 | 14692618 |
| MESH:D014605 |
Uveitis |
|
Cyclosporine |
4.16 | 1336536 |
| MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.77 | 12125929 |
| MESH:D020246 |
Venous Thrombosis |
|
Ethinyl Estradiol |
3.65 | 14671159 15869587 |
| MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.42 | 15886252 |
| MESH:D014985 |
Xerophthalmia |
|
Cyclosporine |
4.62 | 17120751 |